Plant extracts that inhibit bcl-2 gene overexpression hold significant potential as anticancer agents or lead compounds in drug development, given their regulatory influence on cell growth, proliferation, cell cycle, DNA repair, and tumour development (Zhang et al., 2021). This evidence concerns the gene BCL2 and neoplasm.